Model of Helicobacter pylori treatment and disease outcome: a threshold analysis
An infection with Helicobacter pylori and the ensuing gastroduodenitis are considered the most important pathophysiological mechanisms in the development of common peptic ulcer disease that is not secondary to intake of non-steroidal anti-inflammatory drugs (NSAIDs)1,2. Several decision analyses have shown antibiotic eradication of H. pylori to be more cost-effective than other previous treatment modalities of peptic ulcer disease3–5. There is little doubt among gastro-enterologists that all ulcers caused by H. pylori should be treated with antibiotics. Occasionally, other factors may contribute to the development of peptic ulceration, and the correct mode of ulcer management becomes questionable.
KeywordsPeptic Ulcer Duodenal Ulcer Maintenance Therapy Pylorus Eradication Ulcer Patient
Unable to display preview. Download preview PDF.
- 20.First DataBank Division. Price alert. The official guide to average wholesale pricing. November 1993.Google Scholar
- 21.US Department of Commerce. Survey of current business. September 1993, p. 74.Google Scholar
- 22.Veldhuyzen van Zanten SJO, Tytgat KMAJ, deGara CJ et al. A prospective comparison of symptoms and five diagnostic tests in patients with Helicobacter pylori positive and negative dyspepsia. Eur J Gastroenterol Hepatol. 1991;3:463–8.Google Scholar
- 25.Sonnenberg A. Peptic ulcer. In: Everhart JE, editor. Digestive diseases in the United States: epidemiology and impact. US Department of Health and Human Services. Washington, DC: US Government Printing Office, 1994; NIH publication no. 94–1447:357–408.Google Scholar